Results 1 to 10 of about 93,603 (306)
Treatment resistant depression in women with peripartum depression [PDF]
Background Peripartum depression is a leading cause of disease burden for women and yet there is little evidence as to how often peripartum depression does not respond to treatment and becomes treatment resistant depression.
M. Soledad Cepeda +2 more
doaj +3 more sources
Neuromodulation therapies and treatment-resistant depression
Khalid Saad Al-Harbi,1 Naseem Akhtar Qureshi21National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia; 2General Administration for Research and Studies and Mental Health and Social Services, Riyadh, Saudi ArabiaBackground: Patients ...
Al-Harbi KS, Qureshi NA
doaj +1 more source
Treatment-resistant depression: therapeutic trends, challenges, and future directions
Khalid Saad Al-HarbiMedical College, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi ArabiaBackground: Patients with major depression respond to antidepressant treatment, but 10%–30%
Al-Harbi KS
doaj +2 more sources
Ketamine for treatment resistant depression in individuals with eating disorders: a comparison study [PDF]
Background Individuals with eating disorders (EDs) have an increased risk of treatment resistant depression (TRD) and treatment resistant bipolar disorder (TRBD) and a higher rate of suicidal ideation and death by suicide than individuals without EDs ...
Elizabeth Wassenaar +7 more
doaj +2 more sources
CHALLENGES OF TREATMENT-RESISTANT DEPRESSION
Guidelines for the management of treatment-resistant depression (TRD) do not meet the criteria of evidence-based medicine and better-quality research is required to inform clinical practice.
Pandarakalam, James Paul +1 more
core +4 more sources
The role of immunomodulators in treatment-resistant depression: case studies
Depression is a common mental disorder affecting more than 264 million people worldwide. The first-line treatment for most cases of depression are selective serotonin reuptake inhibitors (SSRIs), such as sertraline, reboxetine and fluoxetine.
Charles W. Beckett +1 more
doaj +2 more sources
Treatment-resistant depression (TRD) is common and associated with multiple serious public health implications. A consensus definition of TRD with demonstrated predictive utility in terms of clinical decision-making and health outcomes does not currently
Josefina Ly-Uson
exaly +1 more source
IntroductionAmong treatment-resistant depression (TRD), we identified anergic-anhedonic clinical presentations (TRAD) as putatively responsive to pro-dopaminergic strategies.
Ludovic Christophe Dormegny-Jeanjean +47 more
doaj +1 more source
Ketamine in treatment-resistant depression
Sana Dhamija +2 more
doaj +5 more sources
Treatment-resistant depression reconsidered
The term treatment-resistant depression (TRD) has been the focus of hundreds of studies and clinical trials, though it is not a diagnosable mental health condition according to current clinical standards.
Hans S. Schroder +2 more
doaj +1 more source

